NCT01000636View on ClinicalTrials.gov

Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® Photodynamic Therapy (PDT)

PHASE4CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Actinic Keratosis
Interventions
PROCEDURE

Metvix PDT

"Methyl aminolevulinate cream will be applied for 3 hours on the whole target field.~The target field will then be exposed to red light using Aktilite 128 lamp."

Trial Locations (1)

M13 9WL

Department of Dermatology of Manchester Royal Infirmary, Manchester

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY